skip to content »

Translational Biology & Molecular Medicine

Houston, Texas

Benchtop, Research, Bedside and Application
Translational Biology & Molecular Medicine Graduate Program
not shown on screen

Rachel Atkinson, Ph.D.

Rachel Atkinson

Department of Molecular and Cellular Biology

Thesis Title: Thermal Enhancement with Optically Activated Gold Nanoshells Sensitizes Breast Cancer Stem Cells to Radiation Therapy

Basic Science Mentor: Jeffrey Rosen, Ph.D.
Department of Molecular and Cellular Biology

Clinical Science Mentor: Jenny Chang, M.D.
Department of Medicine

Education:
Ph.D., Translational Biology and Molecular Medicine, Baylor College of Medicine, 2010
B.S., Biology, Washburn University
B.A., Chemistry, Washburn University

Position after graduation: Cancer Prevention Fellowship at M.D. Anderson Cancer Center working with Abenaa Brewster, M.D./M.H.S, in the Department of Clinical Cancer Prevention, and Wendy Woodward, M.D/Ph.D., in the Radiation Oncology department.

Awards and Honors

  • Bristol-Myers Squibb AACR Scholar-in-Training Award, 2010
  • CTRC-AACR San Antonio Breast Cancer Basic Science Scholars Scholarship, 2009
  • Society of Thermal Medicine Travel Award, 2009
  • Frontiers of Cancer Research: Therapeutics Award, 2009

Publications

  • Atkinson R, Zhang M, Diagaradjane P, Peddibhotla S, Contreras A, Krishnan S, Chang J, Rosen J. Thermal Enhancement with Optically Activated Gold Nanoshells Sensitizes Breast Cancer Stem Cells to Radiation Therapy. Science Translational Medicine. Submitted.
  • Zhang M, Atkinson RL, Rosen JM. Selective targeting of radiation-resistant tumor-initiating cells. PNAS. 2010. 107 (8) 3522-7.
  • Zhang M, Behbod F, Atkinson RL, Landis MD, Kittrell F, Edwards D, Medina D, Tsimelzon A, Hilsenbeck S, Green JE, Michalowska AM, Rosen JM. Identification of tumor-initiating cells in a p53-null mouse model of breast cancer. Cancer Res. 2008. 68(12):4674-82.
  • Foster AE, Leen AM, Lee T, Okamura T, Lu A, Vera J, Atkinson R, Bollard CM, Dotti G, Rooney CM. Autologous designer antigen-presenting cells by gene modification of T lymphocyte blasts with IL-7 and IL-12. J Immunotherapy. 2007. 30:506-16.

E-mail this page to a friend